Zhang, Z.; Xiong, Q.; Xu, Y.; Cai, X.; Zhang, L.; Zhu, Q.
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. J. Clin. Med. 2023, 12, 1398.
https://doi.org/10.3390/jcm12041398
AMA Style
Zhang Z, Xiong Q, Xu Y, Cai X, Zhang L, Zhu Q.
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Journal of Clinical Medicine. 2023; 12(4):1398.
https://doi.org/10.3390/jcm12041398
Chicago/Turabian Style
Zhang, Zhiwei, Qunli Xiong, Yongfeng Xu, Xuebin Cai, Lisha Zhang, and Qing Zhu.
2023. "The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma" Journal of Clinical Medicine 12, no. 4: 1398.
https://doi.org/10.3390/jcm12041398
APA Style
Zhang, Z., Xiong, Q., Xu, Y., Cai, X., Zhang, L., & Zhu, Q.
(2023). The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Journal of Clinical Medicine, 12(4), 1398.
https://doi.org/10.3390/jcm12041398